ATE380202T1 - Interaktionssystem zur präsentation und entfernung von substanzen - Google Patents
Interaktionssystem zur präsentation und entfernung von substanzenInfo
- Publication number
- ATE380202T1 ATE380202T1 AT98922710T AT98922710T ATE380202T1 AT E380202 T1 ATE380202 T1 AT E380202T1 AT 98922710 T AT98922710 T AT 98922710T AT 98922710 T AT98922710 T AT 98922710T AT E380202 T1 ATE380202 T1 AT E380202T1
- Authority
- AT
- Austria
- Prior art keywords
- presentation
- substances
- removal
- interaction system
- pmma
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
- B01D69/1411—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes containing dispersed material in a continuous matrix
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
- B01D71/401—Polymers based on the polymerisation of acrylic acid, e.g. polyacrylate
- B01D71/4011—Polymethylmethacrylate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Manufacturing & Machinery (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19715504A DE19715504C2 (de) | 1997-04-14 | 1997-04-14 | PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE380202T1 true ATE380202T1 (de) | 2007-12-15 |
Family
ID=7826448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98922710T ATE380202T1 (de) | 1997-04-14 | 1998-04-14 | Interaktionssystem zur präsentation und entfernung von substanzen |
Country Status (9)
Country | Link |
---|---|
US (2) | US6929955B2 (ja) |
EP (2) | EP0975680B1 (ja) |
JP (1) | JP4495258B2 (ja) |
AT (1) | ATE380202T1 (ja) |
AU (1) | AU7525498A (ja) |
CA (1) | CA2287469C (ja) |
DE (2) | DE19715504C2 (ja) |
ES (1) | ES2297886T3 (ja) |
WO (1) | WO1998046648A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19845286A1 (de) * | 1998-10-01 | 2000-04-27 | Udo Dunzendorfer | Beschichtete Trägermaterialien für Blut-, Plasma- oder Gewebewäsche und mit diesen Trägermaterialien ausgerüstete Säulen |
DE19909584A1 (de) * | 1999-03-04 | 2000-09-14 | Haemosys Gmbh | Trennverfahren |
DE19915862A1 (de) * | 1999-04-08 | 2000-10-12 | Max Planck Gesellschaft | Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie |
DE19918569A1 (de) * | 1999-04-23 | 2000-12-07 | Haemosys Gmbh | Verfahren zur Diagnose von Krankheiten, pathologischen Zuständen und pathophysiologischen sowie physiologischen Messgrößen |
DE19955341A1 (de) * | 1999-11-17 | 2001-08-02 | Haemosys Gmbh | Blutkompatible Polymeroberflächen |
EP1265639A1 (en) * | 2000-03-20 | 2002-12-18 | Knoll GmbH | The use of anticoagulant agents in the extracorporeal treatment of blood |
KR100345323B1 (ko) * | 2000-04-24 | 2002-07-24 | 학교법인 포항공과대학교 | 나노 자성체 입자들을 포함하는 복합체 |
DE10162521A1 (de) * | 2001-12-19 | 2003-07-17 | Goetz Nowak | Verwendung von molekulargewichtserweiterten Substanzen in der Tumortherapie |
EP1443058A1 (en) * | 2003-01-29 | 2004-08-04 | Firmenich Sa | Polymeric particles and fragrance delivery systems |
DE10330900B4 (de) † | 2003-07-01 | 2006-09-14 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt |
EG23584A (en) * | 2003-11-11 | 2006-09-11 | Ali Mokhtar Al-Hossary Amr | Elimination of myoglobin from blood using an i v filter |
US9561309B2 (en) * | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
DE102005001162A1 (de) * | 2005-01-10 | 2006-07-20 | Haemosys Gmbh | Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma |
BRPI0618084A2 (pt) * | 2005-11-14 | 2011-08-16 | Univ Montreal | composições farmacêuticas compreendendo aglutinantes poliméricos com ligações covalentes não hidrolisáveis e seus usos no tratamento da doença celìaca |
DE102007033787A1 (de) | 2007-07-09 | 2009-01-15 | Aesculap Ag | Gefäßprothese mit reduzierter Thrombogenität |
DE102008000220A1 (de) * | 2008-02-01 | 2009-08-13 | ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. | Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung |
EP2316931B1 (de) | 2009-10-30 | 2016-12-28 | Senova Gesellschaft für Biowissenschaft und Technik mbH | Polymergekoppelte Peptidasen |
EP2620162A1 (de) | 2012-01-27 | 2013-07-31 | Life Science Inkubator | Enzym-Polymer-Konjugat zur Endotoxin-Detoxifikation |
PT2892560T (pt) * | 2012-09-06 | 2019-10-18 | Adelaide Research&Innovation Pty Ltd | Métodos e produtos para prevenção e/ou tratamento do cancro metastático |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1603393A (ja) * | 1967-12-27 | 1971-04-13 | ||
JPS4867382A (ja) * | 1971-12-06 | 1973-09-14 | ||
GB1484564A (en) * | 1974-07-24 | 1977-09-01 | Koch Light Labor Ltd | Stable support material for enzyme insolubilisation |
FR2321520A1 (fr) * | 1975-08-22 | 1977-03-18 | Rhone Poulenc Ind | Latex de polymeres possedant des groupes-cn |
DE2552510C3 (de) | 1975-11-22 | 1981-02-19 | Behringwerke Ag, 3550 Marburg | Biologisch aktive Verbindungen und Verfahren zu ihrer Herstellung |
DE2712344C2 (de) * | 1977-03-21 | 1982-09-23 | Hans Dr. 4803 Steinhagen Bünemann | Löslicher Komplexbildner für die affinitätsspezifische Trennung von Nukleinsäuren |
JPS57170263A (en) * | 1981-04-14 | 1982-10-20 | Kuraray Co | Absorber for blood protein |
US4575539A (en) * | 1985-06-03 | 1986-03-11 | E. R. Squibb & Sons, Inc. | Drug delivery systems including novel interpenetrating polymer networks and method |
JPH01310668A (ja) | 1988-06-09 | 1989-12-14 | Nikkiso Co Ltd | 中空糸型血液浄化装置 |
CA1335142C (en) | 1989-07-18 | 1995-04-04 | Leon Edward St-Pierre | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
SE467309B (sv) * | 1990-10-22 | 1992-06-29 | Berol Nobel Ab | Hydrofiliserad fast yta, foerfarande foer dess framstaellning samt medel daerfoer |
AU668855B2 (en) * | 1990-10-26 | 1996-05-23 | Genta Incorporated | Non-aromatic organic polymeric reagents for solid phase synthesis of oligomers |
JPH06256394A (ja) * | 1991-08-13 | 1994-09-13 | Kirin Amgen Delaware Inc | 修飾インターロイキン6 |
DE4203965A1 (de) | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
US5578442A (en) * | 1992-03-23 | 1996-11-26 | Vivorx, Inc. | Graft copolymers of polycationic species and water-soluble polymers, and use therefor |
DE4322884A1 (de) | 1992-10-09 | 1994-04-14 | Bayer Ag | Biologisch aktive Polymere |
US5414075A (en) * | 1992-11-06 | 1995-05-09 | Bsi Corporation | Restrained multifunctional reagent for surface modification |
ATE190633T1 (de) * | 1993-04-27 | 2000-04-15 | Cytotherapeutics Inc | Membran aus einem acrylnitrilpolymer |
FR2724461B1 (fr) * | 1994-09-09 | 1996-12-20 | Prolabo Sa | Microsphere de latex biotinylee, procede de preparation d'une telle microsphere et utilisation en tant qu'agent de detection biologique |
US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
US5752974A (en) * | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
DE19625642A1 (de) | 1996-06-26 | 1998-01-08 | Max Planck Gesellschaft | Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren |
-
1997
- 1997-04-14 DE DE19715504A patent/DE19715504C2/de not_active Expired - Fee Related
-
1998
- 1998-04-14 DE DE59814134T patent/DE59814134D1/de not_active Expired - Lifetime
- 1998-04-14 WO PCT/EP1998/002183 patent/WO1998046648A1/de active IP Right Grant
- 1998-04-14 AU AU75254/98A patent/AU7525498A/en not_active Abandoned
- 1998-04-14 AT AT98922710T patent/ATE380202T1/de active
- 1998-04-14 CA CA2287469A patent/CA2287469C/en not_active Expired - Fee Related
- 1998-04-14 JP JP54349698A patent/JP4495258B2/ja not_active Expired - Fee Related
- 1998-04-14 EP EP98922710A patent/EP0975680B1/de not_active Expired - Lifetime
- 1998-04-14 EP EP07122292A patent/EP1921094A3/de not_active Withdrawn
- 1998-04-14 ES ES98922710T patent/ES2297886T3/es not_active Expired - Lifetime
-
1999
- 1999-10-14 US US09/417,534 patent/US6929955B2/en not_active Expired - Fee Related
-
2005
- 2005-06-29 US US11/170,666 patent/US7494824B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4495258B2 (ja) | 2010-06-30 |
CA2287469C (en) | 2010-02-09 |
EP1921094A3 (de) | 2009-06-24 |
AU7525498A (en) | 1998-11-11 |
US6929955B2 (en) | 2005-08-16 |
DE19715504A1 (de) | 1998-10-15 |
WO1998046648A1 (de) | 1998-10-22 |
US20050239131A1 (en) | 2005-10-27 |
EP1921094A2 (de) | 2008-05-14 |
EP0975680B1 (de) | 2007-12-05 |
EP0975680A1 (de) | 2000-02-02 |
ES2297886T3 (es) | 2008-05-01 |
JP2001527539A (ja) | 2001-12-25 |
US7494824B2 (en) | 2009-02-24 |
DE19715504C2 (de) | 2000-10-26 |
CA2287469A1 (en) | 1998-10-22 |
DE59814134D1 (de) | 2008-01-17 |
US20020028201A1 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59814134D1 (de) | Interaktionssystem zur präsentation und entfernung von substanzen | |
ATE263579T1 (de) | Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel | |
DE69636507D1 (de) | Blutbehälter, sowie Instrument und Gerät zur Abgabe von Blut | |
ATE276762T1 (de) | Stabile lyophilisierte pharmazeutische zubereitungen von mono- oder polykonalen antikörpern | |
DK0608313T3 (da) | Formuleringer af blodkoagel-polymer-matrix ved afgivelse af osteogene proteiner | |
DE68909242D1 (de) | Adhäsives mittel zur arzneistoffabgabe. | |
DE60117615D1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
DE69805772D1 (de) | Stabilisierte mischung auf fibrinogenbasis | |
DE69624065D1 (de) | Kompaktes gerät zur kultivierung von blut | |
DE69432582T2 (de) | System zur Administration von Flüssigkeiten bei mehreren Patienten | |
DE69828895D1 (de) | Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen | |
DE68928638T2 (de) | Polyethylenglycol (peg)-protein addukte und prozess zu ihrer auftrennung | |
DE69722388D1 (de) | Nichtpolymere epoxyverbindungen zur vernetzung von biologischem gewebe und daraus hergestellte bioprothesen | |
DK0600866T3 (da) | Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler | |
DE69833948D1 (de) | Aktives system zur frühen zerstörung von schleppwirbeln | |
DE59610469D1 (de) | Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate | |
DE19681291T1 (de) | Abwärtskompatibles Plattenlaufwerksystem und Wechselplatte | |
KR970702733A (ko) | 활성물질의 방출 조절용 콜라겐 제제(collagen preparation the controlled release of active substances) | |
DE50003454D1 (de) | Proteinenthaltende pharmazeutische zubereitung | |
DE69714451D1 (de) | Prionbindende proteine und deren verwendungen | |
FR2730411B1 (fr) | Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes | |
EP0821965A3 (de) | Verwendung von (Meth)arcylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut | |
ITMI942663A0 (it) | Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono | |
DE69835426D1 (de) | Aktivierung von peptiden | |
DE69722623D1 (de) | Verabreichungssystem von funktionellen wirkstoffen |